Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients

Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients

Abstract Background Growing evidence shows the effects of psychotropic drugs on the evolution of dementia. Until now, only a few studies have evaluated the cost-effectiveness of psychotropic drugs in institutionalized dementia patients. This study aims to assess the cost-utility of intervention perf...

Full description

Bibliographic Details
Main Authors: Mireia Massot Mesquida, Frans Folkvord, Gemma Seda, Francisco Lupiáñez-Villanueva, Pere Torán Monserrat
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Geriatrics
Subjects:
Cost-benefit analysis
Patient-centered medication review
Dementia
Psychotropic drugs
Nursing homes
Institutionalized patients
Online Access:https://doi.org/10.1186/s12877-021-02287-7

Internet

https://doi.org/10.1186/s12877-021-02287-7

Similar Items